C. Schwartz

发表

Survivors of Childhood and Adolescent Cancer

L. Constine, K. Ruccione, W. Hobbie, 2008 .

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Paul A Meyers, Mark D Krailo, E. Kleinerman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic health conditions in adult survivors of childhood cancer.

Kevin C Oeffinger, Wendy Leisenring, Leslie L Robison, 2006, The New England journal of medicine.

Pediatric classical Hodgkin lymphoma

K. Kelly, L. Constine, K. Roberts, 2021, Pediatric blood & cancer.

Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate‐risk Hodgkin lymphoma treated with chemo‐radiation therapy: FDG‐PET parameter analysis in a subgroup from COG AHOD0031

Steve Y. Cho, J. Leal, K. Kelly, 2021, Pediatric blood & cancer.

Subsequent malignant neoplasms among children with Hodgkin lymphoma: A report from the Children's Oncology Group.

K. Kelly, L. Constine, D. Friedman, 2020, Blood.

Predictors of early response and event-free survival in Hodgkin lymphoma (HL): PET versus CT imaging.

L. Constine, D. Friedman, K. McCarten, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The management of Hodgkin disease in the young child

C. Schwartz, 2003, Current opinion in pediatrics.

Long-term survivors of childhood cancer: the late effects of therapy.

C. Schwartz, 1999, The oncologist.

Late effects of treatment in long-term survivors of cancer.

C. Schwartz, 1995, Cancer treatment reviews.

Osteogenic Sarcoma Associated With Diamond–Blackfan Anemia: A Report From the Diamond–Blackfan Anemia Registry

J. Lipton, C. Schwartz, L. Hilliard, 2001, Journal of pediatric hematology/oncology.

Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children’s Oncology Group protocol AHOD0031

K. Kelly, D. Friedman, K. McCarten, 2018, Pediatric Radiology.

American College of Radiology Acr Appropriateness Criteria ® Pediatric Hodgkin Lymphoma Expert Panel on Radiation Oncology–lymphoma: Summary of Literature Review

R. Advani, C. Flowers, A. Ng, 2013 .

POG 8625: A Randomized Trial Comparing Chemotherapy With Chemoradiotherapy for Children and Adolescents With Stages I, IIA, IIIA1 Hodgkin Disease: A Report from the Children's Oncology Group

F. Behm, W. London, F. Kung, 2006, Journal of pediatric hematology/oncology.

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients

Steve Y. Cho, R. Jeraj, K. Kelly, 2020, EJNMMI Physics.

Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031.

L. Constine, T. Fitzgerald, F. Laurie, 2018, International journal of radiation oncology, biology, physics.

Understanding predictors of continued long‐term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors

L. Diller, N. Kadan-Lottick, C. Schwartz, 2017, Pediatric blood & cancer.

Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study.

K. Kelly, S. Bhatia, D. Friedman, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer.

W. Hobbie, C. Schwartz, E. Clark, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.

C. Schwartz, P. D. de Alarcon, T. Trippett, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pulmonary Effects of Antineoplastic Therapy

L. Constine, C. Schwartz, D. Weiner, 2015, Survivors of Childhood and Adolescent Cancer.

Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis

R. Advani, R. Gascoyne, Sonali M. Smith, 2018, Cancer.

Prognostic factors in pediatric Hodgkin disease

C. Schwartz, 2003, Current oncology reports.

ACR appropriateness Criteria® pediatric Hodgkin lymphoma

R. Advani, C. Flowers, A. Ng, 2014, Pediatric blood & cancer.

Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group

Steve Y. Cho, K. Kelly, K. Roberts, 2019, British journal of haematology.

EARLY [18F]FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY–BASED RESPONSE EVALUATION AFTER TREATMENT WITH GEMCITABINE AND VINORELBINE FOR REFRACTORY HODGKIN DISEASE: A CHILDREN’S ONCOLOGY GROUP REPORT

K. McCarten, C. Schwartz, T. Trippett, 2010 .

Management of Adolescent Patients With Hodgkin's Disease in Cooperative Group Trials

L. Constine, T. Fitzgerald, F. Laurie, 2007 .

Chronic health conditions in adult survivors of childhood cancer.

M. Hudson, L. Robison, T. Kawashima, 2006, The New England journal of medicine.

Creating a bridge for transition: From pediatric cancer survival to life‐long, risk‐based health care of the adult cancer survivor

C. Schwartz, 2020, Cancer.

Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group.

J. Meza, K. Kelly, D. Friedman, 2015, Journal of adolescent and young adult oncology.

Health status of childhood cancer survivors: cure is more than the eradication of cancer.

C. Schwartz, 2003, JAMA.

Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease

C. Schwartz, D. Harrison, 2017, Current Treatment Options in Oncology.

A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study

Hao Liu, R. P. Guillerman, N. Agrawal, 2015, British journal of haematology.

Response‐dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: A report from the Children's Oncology Group

T. Fitzgerald, W. London, C. Schwartz, 2012, Pediatric blood & cancer.

Antibody responses to Epstein‐Barr virus‐encoded latent membrane protein‐1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease

E. Bloemena, Jaap M Middeldorp, S. Grufferman, 2002, Journal of medical virology.

Health status of adult long-term survivors of childhood cancer:a report from the Childhood Cancer Survivor Study.

C. Schwartz, 2004, The Journal of pediatrics.

Successful treatment of a child with late onset T‐cell post‐transplant lymphoproliferative disorder/lymphoma

Allen R. Chen, R. Arceci, P. Colombani, 2008, Pediatric blood & cancer.

Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031.

K. Kelly, L. Constine, D. Friedman, 2022, Journal of adolescent and young adult oncology.

Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients

D. Scott, A. Mottok, C. Steidl, 2015 .

Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group

Steve Y. Cho, K. Kelly, K. Roberts, 2015 .

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Lymphoma (HL)

L. Constine, K. McCarten, C. Schwartz, 2010 .

Outcomes in intermediate‐risk pediatric lymphocyte‐predominant Hodgkin lymphoma: A report from the Children's Oncology Group

K. Kelly, D. Friedman, A. Buxton, 2018, Pediatric blood & cancer.

Radiotherapy quality assurance report from children's oncology group AHOD0031.

L. Constine, T. Fitzgerald, F. Laurie, 2015, International journal of radiation oncology, biology, physics.

Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.

A. Ng, G. Lyman, M. Hudson, 2008, International journal of radiation oncology, biology, physics.

In reply [2]

L. Constine, D. Friedman, R. Sposto, 2007 .

Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin.

J. Kurtzberg, C. Civin, C. Schwartz, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma

C. Schwartz, K. Lucas, J. Kaplan, 2008, Pediatric blood & cancer.

Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group

L. Constine, A. Buxton, K. McCarten, 2018, Cancer.

Surgeon Concordance in the Assessment of Resectability for Stage IA Nodular Lymphocyte Predominant Hodgkin Lymphoma.

K. Kelly, P. Ehrlich, C. Schwartz, 2018, Journal of pediatric hematology/oncology.

Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma.

James R. Anderson, C. Paidas, A. Pappo, 2000, Journal of Pediatric Surgery.

Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer

S. Colan, W. Leisenring, L. Constine, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.

M. Somerfield, C. Shapiro, D. Vaughn, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Parental needs for information related to neurocognitive late effects from pediatric cancer and its treatment

E. Jelalian, C. Schwartz, P. Manley, 2009, Pediatric blood & cancer.

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

P. Meltzer, M. Ladanyi, E. Kleinerman, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

M. Sydes, P. Leavey, R. Goldsby, 2019, European journal of cancer.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

K. S. Hall, M. Sydes, P. Leavey, 2016, The Lancet. Oncology.

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)

D. Neuberg, S. Sallan, L. Silverman, 2009, Leukemia.

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia.

D. Neuberg, S. Sallan, L. Silverman, 2010, Blood.

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

E. Kleinerman, A. Huvos, J. Healey, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HER‐2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study

R. Randall, M. Bernstein, K. Janeway, 2014, Pediatric blood & cancer.

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.

M. Link, M. Devidas, M. Gebhardt, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bacteremia in febrile nonneutropenic pediatric oncology patients

M. Kelly, C. Schwartz, P. Vivier, 2010, Pediatric blood & cancer.

Pediatric Hodgkin Lymphoma.

K. Kelly, K. Dieckmann, R. Kluge, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

C. S. Turner, L. Constine, S. Lipshultz, 2009, Blood.

Special issues in pediatric Hodgkin's disease

C. Schwartz, 2005 .

Phase I I/III T rial o f E toposide a nd H igh-Dose I fosfamide in N ewly D iagnosed M etastatic O steosarcoma: A P ediatric Oncology G roup T rial

M. Link, M. Devidas, M. Gebhardt, 2002 .

Orthostatic intolerance in survivors of childhood cancer.

C. Schwartz, K. Ruble, P. Rowe, 2007, European journal of cancer.

Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group

K. Janeway, R. Gorlick, P. Meyers, 2018, Pediatric blood & cancer.

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group

W. Leisenring, L. Constine, S. Lipshultz, 2021, Cancer.

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group

S. Lipshultz, J. Healey, M. Devidas, 2016, Pediatric blood & cancer.

Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.

W. Leisenring, L. Constine, S. Lipshultz, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.

D. Neuberg, S. Sallan, L. Silverman, 2011, European journal of cancer.

ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.

R. Advani, J. Friedberg, C. Flowers, 2010, Current problems in cancer.

Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event‐free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group

K. Kelly, L. Constine, D. Friedman, 2017, Pediatric blood & cancer.

and adolescents with newly diagnosed acute lymphoblastic leukemia Intravenous PEG-asparaginase during remission induction in children

D. Neuberg, S. Sallan, K. Stevenson, 2013 .

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee

M. Gebhardt, L. Teot, K. Janeway, 2016, Pediatric blood & cancer.

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.

H. Lehmann, C. Schwartz, A. Friedmann, 2002, Transfusion medicine reviews.

Radiation-associated cardiovascular disease: manifestations and management.

L. Constine, L. F. Fajardo, S. Lipshultz, 2003, Seminars in radiation oncology.

Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma.

D. Friedman, A. Buxton, R. Ambinder, 2017, Blood advances.

Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group.

Zhengjia Chen, M. Bernstein, L. Teot, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survivor Study Cancer Childhood Cancer: A Report From the Childhood Health Status of Adult Long-term Survivors of

C. Schwartz, 2010 .

Creating life on the plateau: reproductive potential in survivors of childhood Hodgkin's disease.

C. Schwartz, 1990, International journal of radiation oncology, biology, physics.

Endocrine late effects among survivors of cancer.

W. Hobbie, C. Schwartz, Wendy L. Hobble, 1989, Seminars in oncology nursing.

Survivorship

C. Schwartz, D. Harrison, 2015, Journal of surgical oncology.

Outcome for adolescent and young adult patients with osteosarcoma

Paul A Meyers, Mark D Krailo, Richard Gorlick, 2012, Cancer.

APE chemotherapy for children with relapsed Hodgkin disease: A Pediatric Oncology Group trial

W. London, C. Schwartz, P. D. de Alarcon, 2006, Pediatric blood & cancer.

Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group.

L. Constine, A. Buxton, P. Ehrlich, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Special issues in pediatric Hodgkin's disease.

C. Schwartz, 2005, European journal of haematology. Supplementum.

Spinal growth in children irradiated to the craniospinal axis for brain tumors

D. Nelson, P. Rubin, L. Constine, 1994 .

Survivors of childhood and adolescent cancer : a multidisciplinary approach

C. Schwartz, 2005 .

Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia.

R. Gelber, S. Sallan, E. Thompson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.

T. Slovis, L. Constine, S. Kaste, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group

S. Lipshultz, M. Bernstein, K. Janeway, 2019, Cardio-Oncology.

Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.

M. Hudson, L. Constine, A. Muhs, 2008, International journal of radiation oncology, biology, physics.

Analysis of serum insulin growth factor‐1 concentrations in localized osteosarcoma: A children's oncology group study

J. Toretsky, M. Bernstein, A. Goorin, 2014, Pediatric blood & cancer.

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.

Allen R. Chen, L. Constine, T. Fitzgerald, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.

L. Constine, D. Friedman, R. Sposto, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II.

R. Advani, J. Friedberg, C. Flowers, 2011, Journal of the American College of Radiology : JACR.

Cardiometabolic risk in childhood cancer survivors: a report from the Children's Oncology Group.

L. Constine, S. Lipshultz, S. Bhatia, 2021, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

The optic nerve as the site of initial relapse in childhood acute lymphoblastic leukemia

N. Miller, M. Wharam, C. Schwartz, 1989, Cancer.

Motor and perceptual timing deficits among survivors of childhood leukemia.

S. Mostofsky, E. Mahone, C. Schwartz, 2007, Journal of pediatric psychology.

Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol.

K. Kelly, D. Friedman, C. Schwartz, 2018, Blood.

Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response‐based chemotherapy on pediatric protocols: A Children's Oncology Group report

L. Constine, C. Schwartz, P. D. de Alarcon, 2017, Pediatric blood & cancer.

Dose‐finding study of 153Sm‐EDTMP in patients with poor‐prognosis osteosarcoma

G. Sgouros, E. Garrett-Mayer, M. Wharam, 2009, Cancer.

Next Steps: Survivor Healthcare Passport - A Novel Form of Survivorship Care Plan in the Pediatric Population.

R. Phelan, C. Schwartz, Deb Schmidt, 2023, Journal of pediatric hematology/oncology.

P9754 therapeutic intensification in non-metastatic osteosarcoma: A COG trial

M. Devidas, M. Bernstein, A. Goorin, 2004 .

P9754 therapeutic intensification in non-metastatic osteosarcoma: A COG trial.

M. Devidas, M. Bernstein, A. Goorin, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia

M. Sulis, K. Moons, Y. Shyr, 2017, Cancer.

Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: A children's oncology group report

W. London, C. Schwartz, P. D. de Alarcon, 2015, Pediatric blood & cancer.

The current status of follow‐up services for childhood cancer survivors, are we meeting goals and expectations: A report from the consortium for New England childhood cancer survivors

L. Diller, N. Kadan-Lottick, C. Schwartz, 2011, Pediatric blood & cancer.

Gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.

R. Gascoyne, D. Scott, A. Mottok, 2021, Blood.

Variant histology, IgD and CD30 expression in low‐risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group

L. Constine, A. Buxton, P. Ehrlich, 2018, Pediatric blood & cancer.

Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.

K. Kelly, L. Constine, D. Friedman, 2016, International journal of radiation oncology, biology, physics.

Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials.

K. Kelly, S. Bhatia, D. Friedman, 2022, The Lancet. Haematology.

Late mortality and relapse after dexrazoxane (DRZ) treatment: An update from the Children’s Oncology Group (COG).

W. Leisenring, L. Constine, S. Lipshultz, 2014 .

The effects of dexrazoxane on cardiac status and second malignant neoplasms (SMN) in doxorubicin-treated patients with osteosarcoma (OS).

S. Lipshultz, M. Bernstein, K. Janeway, 2012 .

Automated deep learning-based quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric lymphoma patients

Steve Y. Cho, R. Jeraj, K. Kelly, 2020 .

Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01

D. Neuberg, S. Sallan, L. Silverman, 2011 .

Machine learning-based assignment of Deauville scores is comparable to interobserver variability on interim FDG PET/CT images of pediatric lymphoma patients

Steve Y. Cho, R. Jeraj, K. Kelly, 2020 .

Survivors of Childhood Cancer: Assessment and Management

W. Hobbie, C. Schwartz, 1994 .

Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group.

L. Constine, T. Fitzgerald, D. Friedman, 2012, International journal of radiation oncology, biology, physics.

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

W. Leisenring, L. Constine, S. Lipshultz, 2016 .

Pediatric Hodgkin Lymphoma

L. Constine, S. Daw, C. Schwartz, 2020, Hodgkin Lymphoma.

Treatment of Pediatric Lymphocyte Predominant Hodgkin Lymphoma (LPHL): A Report from the Children's Oncology Group

L. Constine, P. Ehrlich, C. Schwartz, 2014 .

Treatment of pediatric stage IA lymphocyte-predominant Hodgkin lymphoma with surgical resection alone: A report from the Children's Oncology Group.

L. Constine, P. Ehrlich, C. Schwartz, 2012 .

Clinical Outcomes of Patients with Recurrent/Refractory Hodgkin Disease Receiving Cyclosporine, Interferon-γ, and Interleukin-2 Immunotherapy To Induce Autoreactivity after Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen R. Chen, L. Constine, C. Schwartz, 2007 .

Treatment of Pediatric Hodgkin Lymphoma

M. Hudson, S. Donaldson, L. Constine, 2007 .

The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

J. Friedberg, K. Kelly, L. Constine, 2021, Blood.

K. S. Hall, M. Sydes, P. Leavey, 2016, The Lancet. Oncology.

The Thyroid Gland

L. Constine, C. Schwartz, Michael T. Milano, 2015 .

In reply [10]

M. Bernstein, L. Teot, A. Goorin, 2007 .

Bacteremia in febrile nonneutropenic pediatric oncology patients

M. Kelly, C. Schwartz, P. Vivier, 2010, Pediatric blood & cancer.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

M. Sydes, P. Leavey, R. Goldsby, 2019, European journal of cancer.

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Allen R. Chen, L. Constine, T. Fitzgerald, 2010 .

ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.

R. Advani, J. Friedberg, C. Flowers, 2010, Current problems in cancer.

Pediatric Hodgkin Lymphoma.

K. Kelly, K. Dieckmann, R. Kluge, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pediatric Hodgkin Lymphoma

L. Constine, S. Daw, C. Schwartz, 2020, Hodgkin Lymphoma.

Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.

K. Kelly, L. Constine, D. Friedman, 2016, International journal of radiation oncology, biology, physics.

Pleural Effusion in Intermediate Hodgkin Lymphoma COG Protocol AHOD0031-Evolution with Therapy and Association with Bulk Mediastinal Disease or Bone, Lung or Pleural Nodular Disease

Steve Y. Cho, D. Friedman, K. McCarten, 2014 .

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

L. Constine, K. McCarten, C. Dunphy, 2014 .

18f-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL). A Preliminary Retrospective Analysis of Children's Oncology Group (COG) AHOD0031

Steve Y. Cho, K. Kelly, D. Friedman, 2012 .

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma

K. Kelly, L. Constine, D. Friedman, 2011 .

A phase II study of bortezomib with ifosfamide and vinorelbine in pediatric patients with refractory/recurrent Hodgkin disease (HD): A Children's Oncology Group (COG) study.

Allen R. Chen, T. Horton, K. McCarten, 2010 .

Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498).

B. Vikram, J. Saltz, J. Purdy, 2010, International journal of radiation oncology, biology, physics.

Improved R esponse W ith H igher C orticosteroid D ose i n Children W ith A cute L ymphoblastic L eukemia

R. Gelber, S. Sallan, C. Schwartz, 2001 .

Survivorship

C. Schwartz, D. Harrison, 2015, Journal of surgical oncology.

Survivors of childhood and adolescent cancer : a multidisciplinary approach

C. Schwartz, 2005 .